Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309584003> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4309584003 endingPage "35" @default.
- W4309584003 startingPage "15" @default.
- W4309584003 abstract "Background: Gene therapy has proved to be a boon for neuromuscular diseases. A concept introduced in the early 1960’s, has been put into clinical practice in the past 5-10 years. The process by which a healthy gene replaces a defective gene in a human body through vectors is truly pathbreaking. Patients with inherited degenerative neuromuscular disorders such as spinal muscular atrophy, and muscular dystrophies undergo progressive deterioration and eventually death. Gene therapy and other adjunctive clinical approaches have provided such patients with a second chance to truly live their life. This review is centered on the different gene therapies currently developed for spinal muscular atrophy and Duchenne muscular dystrophy and also sheds light on the emerging therapies.
 Methods: Literature search was done in Medline, Embase, and Google Scholar. The relevant and important articles were included for developing the narrative review. 
 Results and Discussion: The nusinersen, risdiplam, zolgensma, eteplirsen, golodirsen, viltolarsen, casimersen and ataluren are developed as gene therapies for Spinal muscular atrophy and Duchenne muscular dystrophy. The therapies approved under orphan drug designation have shown muscle strength improvement in clinical trials. However, long-term data on safety and efficacy is to be determined. The cost of the therapies acts as an impediment in most cases.
 Conclusion: The development of gene therapies for inherited genetic disorders would be a prelude for several other genetic diseases. The studies in this arena would provide a prototype for translational research from bench to bedside. Further efforts are mandated towards long term safety, efficacy, and affordability of therapies." @default.
- W4309584003 created "2022-11-28" @default.
- W4309584003 creator A5006678107 @default.
- W4309584003 creator A5036589145 @default.
- W4309584003 creator A5048624020 @default.
- W4309584003 creator A5056508936 @default.
- W4309584003 date "2022-11-19" @default.
- W4309584003 modified "2023-10-04" @default.
- W4309584003 title "Gene Therapies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy: A Pathbreaking Moment in Therapeutics" @default.
- W4309584003 doi "https://doi.org/10.9734/jpri/2022/v34i53b7229" @default.
- W4309584003 hasPublicationYear "2022" @default.
- W4309584003 type Work @default.
- W4309584003 citedByCount "0" @default.
- W4309584003 crossrefType "journal-article" @default.
- W4309584003 hasAuthorship W4309584003A5006678107 @default.
- W4309584003 hasAuthorship W4309584003A5036589145 @default.
- W4309584003 hasAuthorship W4309584003A5048624020 @default.
- W4309584003 hasAuthorship W4309584003A5056508936 @default.
- W4309584003 hasBestOaLocation W43095840031 @default.
- W4309584003 hasConcept C104317684 @default.
- W4309584003 hasConcept C111599444 @default.
- W4309584003 hasConcept C126322002 @default.
- W4309584003 hasConcept C142724271 @default.
- W4309584003 hasConcept C2778558090 @default.
- W4309584003 hasConcept C2778943923 @default.
- W4309584003 hasConcept C2779030066 @default.
- W4309584003 hasConcept C2779134260 @default.
- W4309584003 hasConcept C535046627 @default.
- W4309584003 hasConcept C54355233 @default.
- W4309584003 hasConcept C60644358 @default.
- W4309584003 hasConcept C71924100 @default.
- W4309584003 hasConcept C86803240 @default.
- W4309584003 hasConcept C99508421 @default.
- W4309584003 hasConceptScore W4309584003C104317684 @default.
- W4309584003 hasConceptScore W4309584003C111599444 @default.
- W4309584003 hasConceptScore W4309584003C126322002 @default.
- W4309584003 hasConceptScore W4309584003C142724271 @default.
- W4309584003 hasConceptScore W4309584003C2778558090 @default.
- W4309584003 hasConceptScore W4309584003C2778943923 @default.
- W4309584003 hasConceptScore W4309584003C2779030066 @default.
- W4309584003 hasConceptScore W4309584003C2779134260 @default.
- W4309584003 hasConceptScore W4309584003C535046627 @default.
- W4309584003 hasConceptScore W4309584003C54355233 @default.
- W4309584003 hasConceptScore W4309584003C60644358 @default.
- W4309584003 hasConceptScore W4309584003C71924100 @default.
- W4309584003 hasConceptScore W4309584003C86803240 @default.
- W4309584003 hasConceptScore W4309584003C99508421 @default.
- W4309584003 hasLocation W43095840031 @default.
- W4309584003 hasOpenAccess W4309584003 @default.
- W4309584003 hasPrimaryLocation W43095840031 @default.
- W4309584003 hasRelatedWork W1978943632 @default.
- W4309584003 hasRelatedWork W1997975349 @default.
- W4309584003 hasRelatedWork W2059017658 @default.
- W4309584003 hasRelatedWork W2344301892 @default.
- W4309584003 hasRelatedWork W2615469091 @default.
- W4309584003 hasRelatedWork W2740435222 @default.
- W4309584003 hasRelatedWork W2788314063 @default.
- W4309584003 hasRelatedWork W2803996799 @default.
- W4309584003 hasRelatedWork W2810852991 @default.
- W4309584003 hasRelatedWork W917887554 @default.
- W4309584003 isParatext "false" @default.
- W4309584003 isRetracted "false" @default.
- W4309584003 workType "article" @default.